Last quarter (Q4 2022), Noxopharm Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Noxopharm Ltd.'s net income was AU$―. See Noxopharm Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	-	AU$ 15.21M	AU$ 20.21M	AU$ 16.37M	AU$ 15.68M	AU$ 10.51M
Operating Income	-	AU$ -15.21M	AU$ -20.21M	AU$ -16.37M	AU$ -15.68M	AU$ -10.51M
Net Non Operating Interest Income Expense	-	AU$ -30.39K	AU$ -2.05M	AU$ -3.46M	AU$ -464.21K	AU$ -175.49K
Other Income Expense	-	AU$ -3.43M	AU$ 12.91M	AU$ 18.82M	AU$ 3.57M	AU$ -7.64M
Pretax Income	-	AU$ -18.67M	AU$ -9.35M	AU$ -999.57K	AU$ -12.57M	AU$ -18.32M
Tax Provision	-	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -18.67M	AU$ -9.35M	AU$ -272.09K	AU$ -11.22M	AU$ -18.28M
Basic EPS	-	AU$ -0.06	AU$ -0.04	AU$ >-0.01	AU$ -0.08	-
Diluted EPS	-	AU$ -0.06	AU$ -0.04	AU$ >-0.01	AU$ -0.08	-
Basic Average Shares	-	AU$ 291.22M	AU$ 263.85M	AU$ 138.36M	AU$ 138.15M	-
Diluted Average Shares	-	AU$ 291.22M	AU$ 263.85M	AU$ 138.36M	AU$ 138.15M	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	AU$ -18.67M	AU$ -9.35M	AU$ -272.09K	AU$ -11.22M	AU$ -18.28M
Normalized Income	-	AU$ -18.67M	AU$ -9.35M	AU$ -272.09K	AU$ -11.22M	AU$ -18.28M
Interest Expense	-	AU$ 77.33K	AU$ 2.19M	AU$ 3.47M	AU$ 650.90K	AU$ 238.30K
EBIT	-	AU$ -18.59M	AU$ -7.16M	AU$ 2.47M	AU$ -11.92M	AU$ -18.08M
EBITDA	-	AU$ -18.33M	AU$ -6.90M	AU$ 2.71M	AU$ -11.86M	AU$ -18.02M

Currency in AUD

Noxopharm Ltd. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing